{"id":"antiplatelet-only-strategy","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Intracranial hemorrhage"}]},"_chembl":{"chemblId":"CHEMBL464738","moleculeType":"Small molecule","molecularWeight":"396.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach uses antiplatelet agents (such as aspirin, P2Y12 inhibitors, or other platelet aggregation inhibitors) as monotherapy to reduce the risk of blood clots and cardiovascular events. Unlike dual antiplatelet therapy (DAPT) or antiplatelet plus anticoagulation combinations, this strategy relies solely on platelet inhibition, potentially reducing bleeding risk while maintaining antithrombotic efficacy in select patient populations.","oneSentence":"An antiplatelet-only strategy inhibits platelet aggregation to prevent thrombotic events without additional anticoagulation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:01:57.361Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome or post-percutaneous coronary intervention management (Phase 3 trial context)"}]},"trialDetails":[{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT07391358","phase":"NA","title":"DAPT Strategy in HBR Patients Undergoing Complex PCI Following ACS: Second-Phase Beta Testing of a Patients Decision Aid","status":"NOT_YET_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-02-01","conditions":"Acute Coronary Syndrome","enrollment":26},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT05832762","phase":"NA","title":"Evaluation of Acute Endovascular Treatment in Symptomatic Isolated Cervical Internal Carotid Artery Occlusion (ETICA)","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07115940","phase":"NA","title":"Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well","status":"NOT_YET_RECRUITING","sponsor":"Amrou Sarraj","startDate":"2026-01-01","conditions":"Acute Ischemic Stroke","enrollment":408},{"nctId":"NCT05650411","phase":"NA","title":"Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)","status":"NOT_YET_RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2026-03-01","conditions":"Left Main Coronary Artery Stenosis","enrollment":828},{"nctId":"NCT07211854","phase":"","title":"Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms","status":"COMPLETED","sponsor":"Franck Assayag","startDate":"2024-09-06","conditions":"Coronary Artery Dilatations and Aneursyms","enrollment":51},{"nctId":"NCT06702436","phase":"","title":"Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)\"","status":"COMPLETED","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2024-06-01","conditions":"Myocardial Infarction","enrollment":12500},{"nctId":"NCT03465644","phase":"PHASE4","title":"TAILored Versus COnventional AntithRombotic StratEgy IntenDed for Complex HIgh-Risk PCI","status":"COMPLETED","sponsor":"Duk-Woo Park, MD","startDate":"2019-02-12","conditions":"Coronary Stenoses","enrollment":2018},{"nctId":"NCT05066789","phase":"PHASE4","title":"CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4","status":"TERMINATED","sponsor":"Samsung Medical Center","startDate":"2022-01-17","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT06541691","phase":"NA","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","status":"RECRUITING","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2024-03-06","conditions":"Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Ischemic Heart Disease","enrollment":3000},{"nctId":"NCT05627375","phase":"PHASE3","title":"Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2023-08-16","conditions":"Venous Thromboembolic Disease","enrollment":1400},{"nctId":"NCT06881901","phase":"","title":"Antiplatelet Strategy for CCS Patients Undergoing CABG","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-01-01","conditions":"Chronic Coronary Syndrome, Coronary Artery Bypass Graft CABG","enrollment":29898},{"nctId":"NCT03729401","phase":"PHASE4","title":"Personalization of Long-Term Antiplatelet Therapy - RAPID EXTEND","status":"SUSPENDED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2019-08-22","conditions":"Coronary Artery Disease, Myocardial Infarction","enrollment":390},{"nctId":"NCT05418556","phase":"PHASE4","title":"Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2022-10-21","conditions":"Coronary Artery Disease","enrollment":3944},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03718559","phase":"PHASE4","title":"Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease","status":"COMPLETED","sponsor":"Gi-Byoung Nam","startDate":"2019-05-14","conditions":"Atrial Fibrillation, Coronary Artery Disease, Stable Angina","enrollment":1040},{"nctId":"NCT06168370","phase":"NA","title":"Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-12-01","conditions":"Severe Aortic Valve Stenosis","enrollment":2500},{"nctId":"NCT06071091","phase":"NA","title":"Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-08","conditions":"Acute Ischemic Stroke","enrollment":346},{"nctId":"NCT05375474","phase":"PHASE4","title":"Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-07-27","conditions":"Transcatheter Aortic Valve Replacement, Antithrombotic Therapy, Bioprosthetic Valve Thrombosis","enrollment":650},{"nctId":"NCT06084000","phase":"NA","title":"STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-10-15","conditions":"Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis","enrollment":2700},{"nctId":"NCT05948969","phase":"NA","title":"Transform CV Risk in Diabetes","status":"UNKNOWN","sponsor":"American College of Cardiology","startDate":"2023-09-01","conditions":"Type 2 Diabetes","enrollment":750},{"nctId":"NCT05085405","phase":"NA","title":"Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-10-11","conditions":"Upper Gastrointestinal Bleeding","enrollment":80},{"nctId":"NCT05671276","phase":"PHASE4","title":"Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-02-01","conditions":"Atrial Fibrillation, Left Atrial Appendage Occlusion, Silent Cerebral Embolism","enrollment":150},{"nctId":"NCT05567536","phase":"","title":"Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2014-03-01","conditions":"Coronary Artery Disease, Atheroscleroses, Coronary","enrollment":5530},{"nctId":"NCT05554822","phase":"PHASE3","title":"Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study","status":"UNKNOWN","sponsor":"Azienda Ospedaliero Universitaria Maggiore della Carita","startDate":"2021-06-14","conditions":"Left Atrial Appendage Occlusion, Antiplatelet Therapy","enrollment":574},{"nctId":"NCT05007054","phase":"","title":"Long-Term Outcomes in Patients With Three-Vessel Disease","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2021-05-01","conditions":"Three Vessel Coronary Disease","enrollment":4300},{"nctId":"NCT04995159","phase":"NA","title":"Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System","status":"NOT_YET_RECRUITING","sponsor":"Lepu Medical Technology (Beijing) Co., Ltd.","startDate":"2021-09","conditions":"Coronary Heart Disease","enrollment":2150},{"nctId":"NCT02548611","phase":"PHASE4","title":"Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention","status":"TERMINATED","sponsor":"LMU Klinikum","startDate":"2015-09","conditions":"Angina Pectoris","enrollment":795},{"nctId":"NCT02833948","phase":"PHASE3","title":"Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT)","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2016-05","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Valve Diseases","enrollment":231},{"nctId":"NCT02556203","phase":"PHASE3","title":"Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes","status":"TERMINATED","sponsor":"Bayer","startDate":"2015-12-16","conditions":"Transcatheter Aortic Valve Replacement","enrollment":1653},{"nctId":"NCT00623623","phase":"PHASE3","title":"STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-03-01","conditions":"Myocardial Infarction","enrollment":1899},{"nctId":"NCT03224923","phase":"PHASE4","title":"A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2017-08-18","conditions":"Stable Coronary Syndrome, Percutaneous Coronary Intervention, Antiplatelet Therapy","enrollment":5},{"nctId":"NCT02362659","phase":"","title":"Antithrombotic Strategy Variability In ATrial Fibrillation and Obstructive Coronary Disease Revascularized With PCI - The AVIATOR 2 Registry","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2015-04","conditions":"Non-valvular Atrial Fibrillation","enrollment":514},{"nctId":"NCT01103440","phase":"PHASE2","title":"Aspirin Resistance and Percutaneous Coronary Intervention (PCI)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2007-04","conditions":"Stable Angina","enrollment":36},{"nctId":"NCT02723981","phase":"PHASE4","title":"COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials","status":"WITHDRAWN","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2016-04","conditions":"Stable Angina, Unstable Angina, STEMI","enrollment":""},{"nctId":"NCT02800174","phase":"NA","title":"Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis","status":"COMPLETED","sponsor":"Beijing Jishuitan Hospital","startDate":"2006-06","conditions":"Carotid Artery Stenosis","enrollment":103}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Antiplatelet-only strategy","genericName":"Antiplatelet-only strategy","companyName":"Icahn School of Medicine at Mount Sinai","companyId":"icahn-school-of-medicine-at-mount-sinai","modality":"Small molecule","firstApprovalDate":"","aiSummary":"An antiplatelet-only strategy inhibits platelet aggregation to prevent thrombotic events without additional anticoagulation. Used for Acute coronary syndrome or post-percutaneous coronary intervention management (Phase 3 trial context).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}